Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept Dosing Regimens in Renal Transplant Recipients
NCT02005562Phase 3Completed
- Sponsor
- Roche
- Start
- May 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in kidney transplant rejection, sponsored by Roche. Started May 2006; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02005562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005562.